<?xml version="1.0" encoding="UTF-8"?>
<p id="Par7">Following the alert, 115 additional cases were tested for viral hepatitis, increasing the overall screening rate to 87.9% (Fig. 
 <xref rid="Fig1" ref-type="fig">1</xref>). Percentage of completed panel of screening according to the epidemiological, clinical, and therapeutic factors of patients is summarized in Table 
 <xref rid="Tab2" ref-type="table">2</xref>. Overall, anti-CD20-containing regimens and DLBCL patients were the ones with the highest screening rates, whereas those receiving tyrosine-kinase inhibitors or and patients CML had the lowest. Mean age of patients with complete viral panel did not differed to those without (62.8 vs 63.5 years, p = 0.7).
</p>
